People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Afferent Pharmaceuticals, Inc. | — | Other Health Care | Series C | $58.1M | $1.3B | 2015 |
Michael Sereda Kitt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Sereda Kitt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Neafus | 1 | 7 |
| Mitchell S. Bloom | 1 | 7 |
| Kevin Starr | 1 | 5 |
| Kathleen Sereda Glaub | 1 | 3 |
| Liam Sereda Ratcliffe | 1 | 2 |
| Peter Sereda Hirth | 1 | 2 |
| Arthur S. Pappas | 1 | 2 |
| Arthur Sereda Pappas | 1 | 1 |
| Anthony Sereda Ford | 1 | 1 |
| Liam S. Ratcliffe | 1 | 1 |
| Jesse Sereda Treu | 1 | 1 |
| Jesse S. Treu | 1 | 1 |
| Kevin Sereda Starr | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.